Presentation is loading. Please wait.

Presentation is loading. Please wait.

Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease  Margien L. Seinen,

Similar presentations


Presentation on theme: "Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease  Margien L. Seinen,"— Presentation transcript:

1 Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease  Margien L. Seinen, Cyriel Y. Ponsioen, Nanne K.H. de Boer, Bas Oldenburg, Gerd Bouma, Chris J.J. Mulder, Adriaan A. van Bodegraven  Clinical Gastroenterology and Hepatology  Volume 11, Issue 6, Pages (June 2013) DOI: /j.cgh Copyright © 2013 AGA Institute Terms and Conditions

2 Figure 1 Flow chart of all CD patients screened and followed up throughout the study. Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh ) Copyright © 2013 AGA Institute Terms and Conditions

3 Figure 2 Kaplan–Meier curve (including 95% CI interval) regarding sustained clinical benefit of monotherapy MTX in CD patients. Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh ) Copyright © 2013 AGA Institute Terms and Conditions


Download ppt "Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease  Margien L. Seinen,"

Similar presentations


Ads by Google